loading page

Hereditary Amyloidosis: insights into a fibrinogen A variant protein
  • +7
  • Nahuel A. Ramella,
  • Elizabeth R. Cattaneo,
  • Romina A. Gisonno,
  • Martín C. Abba,
  • Marianela Santana,
  • Silvana A. Rosú,
  • Elsa Nucifora,
  • María A. Aguirre,
  • María C. Giordani,
  • M. Alejandra Tricerri
Nahuel A. Ramella
Instituto de Investigaciones Bioquimicas de La Plata

Corresponding Author:nramella@med.unlp.edu.ar

Author Profile
Elizabeth R. Cattaneo
Instituto de Investigaciones Bioquimicas de La Plata
Author Profile
Romina A. Gisonno
Institute of Science and Technology Austria
Author Profile
Martín C. Abba
Universidad Nacional de la Plata
Author Profile
Marianela Santana
Instituto de Investigaciones Bioquimicas de La Plata
Author Profile
Silvana A. Rosú
Instituto de Investigaciones Bioquimicas de La Plata
Author Profile
Elsa Nucifora
Hospital Italiano de Buenos Aires
Author Profile
María A. Aguirre
Hospital Italiano de Buenos Aires
Author Profile
María C. Giordani
Hospital Italiano de Buenos Aires
Author Profile
M. Alejandra Tricerri
Instituto de Investigaciones Bioquimicas de La Plata
Author Profile

Abstract

Amyloidosis are a group of diseases in which soluble proteins aggregate and deposit in fibrillar conformation extracellularly in tissues. The effectiveness of therapeutic strategies depends on the specific protein involved, being crucial to accurately determine its nature. Moreover, following the diagnosis, the search for the mutation within relatives allows the clinical advice. Here we report the precise diagnosis and explored the possible reasons of the structural pathogenicity. Whole exome sequencing and GATK calling pipeline were leveraged to characterize the protein variant present in a patient with kidney failure. Bioinformatics strategies were applied to suggest potential explanations of the variants aggregation. Our pipeline allowed the identification of a single point variant of fibrinogen Aα chain, which opened the possibility of curative transplantation. I n silico structural analysis, suggested that the pathogenicity of the variant may be attributed to a heightened susceptibility to yield a peptide prone to deposit as an oligomer with a β-sheet structure. Exploiting the comprehensive coverage of whole genome sequencing we managed to fill a vacant stage in the diagnosis of hereditary amyloidosis and to stimulate the advancement in biomedicine.
19 Feb 2024Submitted to PROTEINS: Structure, Function, and Bioinformatics
18 Apr 2024Review(s) Completed, Editorial Evaluation Pending
26 Apr 2024Editorial Decision: Revise Major
04 Jul 2024Review(s) Completed, Editorial Evaluation Pending
04 Jul 2024Editorial Decision: Accept